Status:
UNKNOWN
Evaluation of the Responsiveness of Investigator Global Assessment Score for Keratosis Pilaris
Lead Sponsor:
Premier Specialists, Australia
Collaborating Sponsors:
The University of New South Wales
Conditions:
Keratosis Pilaris
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This prospective study aims to evaluate the responsiveness of the validated investigator global assessment (IGA) and composite area index score for keratosis pilaris by data collection through treatme...
Detailed Description
This is a prospective study aiming to evaluate the responsiveness of the IGA score for KP. KPAI is a 5-point IGA score (0-4) of five main body areas: face, upper limbs, lower limbs, trunk, and buttock...
Eligibility Criteria
Inclusion
- All genders are allowed to participate
- Age range: 18-80 years
- Participants with Fitzpatrick skin type 1-3
- Those with KP including subtypes of KP on the scored body regions (face, upper limbs, lower limbs, trunk, and buttocks)
- Able to attend the scoring sessions
- Participants having read and understood the PICF and are willing to participate
- Of mature mind and able to provide informed consent
- Able to maintain compliance with required study related procedures including completing the QOL questionnaire's
Exclusion
- Participants who are unwilling or unable to attend the scoring sessions
- Those with other skin conditions overlapping the same area(s) as the KP
- People younger than 18
- People with darker skin i.e. Fitzpatrick skin type 4 or above
- Those who had received any laser or dermabrasion therapy in the previous 6 months or topical treatment (keratolytic agents or corticosteroids) in the previous 1 month before the study treatment session
- Those with a history of keloid or hypertrophic scars
- Those being on photosensitive medications, allergic to intervention agents
- Pregnant or lactating
Key Trial Info
Start Date :
July 26 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 29 2023
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT06032078
Start Date
July 26 2023
End Date
December 29 2023
Last Update
September 11 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Premier Dermatology
Sydney, New South Wales, Australia, 2217
2
Premier Specialists
Sydney, New South Wales, Australia, 2217